Daniel L. Gressel is the owner of Teleos Management, based in Riverside, Connecticut. Teleos began in 1991 and employs a global macro strategy that focuses primarily on fixed income instruments, currencies, and equity indices. In 2012, Teleos converted to a family office that only runs Daniel's own money.
Daniel is also the lead investor in Transalgae, a biotech startup in Israel. Transalgae is genetically modifying algae to enable oral delivery of valuable proteins for use as hormones, vaccines, and insecticides. The company is also growing non-genetically modified algae for immediate sales and to learn how to lower the cost of production.
Daniel has supported free-market think tanks since 1982 in addition to working for one – the Centro de Estudios Publicos in Chile. He currently is the chairman of the board of directors of the Yankee Institute.
Prior to forming Teleos, Daniel worked for GT Management in Hong Kong and San Francisco. Daniel was a professor of economics and a consultant. He taught economics at Baruch College in New York and the Catholic University in Santiago, Chile. He helped write Indonesia's tax law in 1980 and was an adviser in Chile for the implementation of Chile’s privatized social security system. He received a B.S. from the Ohio State University, and an M.A. and Ph.D. in Economics from the University of Chicago. He took the last class Milton Friedman taught at the University of Chicago.
Recent chairmen of the Yankee Institute board:
- Andrew R. Jones
- Former U.S. Rep. Rob Simmons
- Andrew Cowin